WST

WST

USD

West Pharmaceutical Services Inc. Common Stock

$286.940+8.560 (3.075%)

السعر في الوقت الحقيقي

Healthcare
Medical Instruments & Supplies
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$278.380

الأعلى

$287.875

الأدنى

$277.195

الحجم

0.41M

أساسيات الشركة

القيمة السوقية

20.6B

الصناعة

Medical Instruments & Supplies

البلد

United States

إحصاءات التداول

متوسط الحجم

0.64M

البورصة

NYQ

العملة

USD

نطاق 52 أسبوعاً

الأدنى $187.43الحالي $286.940الأعلى $348.9

أخبار ذات صلة

Analyst Upgrades

TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350

TD Cowen analyst Brendan Smith initiates coverage on West Pharmaceutical Servs with a Buy rating and announces Price Target of $350.

عرض المزيد
TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350
Analyst Upgrades

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs with a Equal-Weight and raises the price target from $275 to $325.

عرض المزيد
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325
PR Newswire

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...

عرض المزيد
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Analyst Upgrades

UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355

UBS analyst John Sourbeer maintains West Pharmaceutical Servs with a Buy and raises the price target from $320 to $355.

عرض المزيد
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355
Analyst Upgrades

Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs with a Overweight and raises the price target from $325 to $350.

عرض المزيد
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350
PR Newswire

West to Participate in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $390

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs with a Outperform and raises the price target from $350 to $390.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.